Detection of diverse HIV strains by the m-PIMATM HIV-1/2 detect point-of-care assay
The m-PIMA HIV-1/2 Detect assay detected each of the major circulating HIV strains, including rare divergent strains. In silico analysis predicted that m-PIMA HIV-1/2 Detect would detect the majority of HIV-1 and HIV-2 strains indicating that this assay can detect the full range of HIV viral diversity.
Authors
- Mark H. Anderson (ORCID: https://orcid.org/0000-0002-8483-2714)
- Fiona Harley
- Todd Meyer
- Mary A. Rodgers (ORCID: https://orcid.org/0000-0001-8815-8651)
- Jean‐Christophe Plantier (ORCID: https://orcid.org/0000-0001-6417-4083)
- Barbara J. Harris (ORCID: https://orcid.org/0000-0002-4050-2553)
- Linda James
- Eduardo Almaraz
- Lara I. Teodoro (ORCID: https://orcid.org/0000-0001-5383-3709)
- Carolyn Strobel
- Souleymane Mboup (ORCID: https://orcid.org/0000-0002-7968-3320)
- Ana Vallari
- Nicaise Ndembi (ORCID: https://orcid.org/0000-0002-9498-3428)
- Dora Mbanya
- Gavin Cloherty (ORCID: https://orcid.org/0009-0000-8221-7905)
Institutions
- University of North Carolina at Chapel Hill (US)
- Université de Yaoundé I (CM)
- Abbott (United States) (US)
- Africa Centres for Disease Control and Prevention (ET)
- Institute of Health Research, Epidemiological Surveillance and Training (SN)
- National Radiation Protection Agency of Cameroon (CM)
- Abbott Fund (US)
- Centre Hospitalier Universitaire de Rouen (FR)
- Université de Rouen Normandie (FR)
Publication Details
- Journal
- Journal of Clinical Virology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1016/j.jcv.2025.105771
- Citations
- 1
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.04
Funders
- Abbott Laboratories